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CC BY-NC-ND license (http://creativeWe report on a method to analyze length heteroplasmy within the human mitochondrial
genome in which there are polycytosine [poly(C)] stretches. These poly(C) tracts induce het-
eroplasmy with the resultant inherent problems of accurate sequence designations. In this
study, 20 samples that exhibited length heteroplasmy due to variation in the C-tracts within
hypervariable region I (HVI) were treated with bisulfite, and one or more cytosine bases in
these C-tracts were converted randomly to uracil. This resulted in an accurate sequence desig-
nation for nearly all samples. The only exceptions in which the DNA sequence could still not be
determined occurred when there was total conversion, or a lack of conversion, of the cytosine
bases. Replicate tests on the same samples showed that individual cytosine bases were
randomly converted to uracil. This simple method was useful for investigating length hetero-
plasmy due to 16189C and 310C transitions in the mitochondrial-DNA control region. It is valu-
able for medical and forensic investigations.
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Length heteroplasmy test with bisulfite treatment 285string of cytosine bases. In instances in which the sequence
is not interrupted by a thymine, such as 16189C or 310C, a
subsequent phase shift pattern occurs in the downstream
sequence following the C-tracts of one or more bases. This
phase shift creates uncertainty in the number of cytosine
bases and makes the subsequent DNA sequence difficult to
interpret.
Instances of length heteroplasmy have been studied
because of their relationship with a variety of diseases such
as diabetes or other metabolic conditions, although several
reports do not consistently reproduce an association of
common mtDNA variants with the diseases.4,5 Length vari-
ants because of heteroplasmy have been reported in
forensic and anthropological studies in which a complex
DNA sequence could not be easily resolved, and multiple
amplicons from a single sample existed in nearly all such
studies.6,7 Subsequent cloning of amplicons results in
length variants within a single clone.6,8,9
Bisulfite has been used to determine patterns of DNA
methylation.10 It will convert cytosine bases to uracil but
leaves methylated cytosine bases unaffected and has been
used in medically related studies.11 The aim and outcome
of previous reports was for the total conversion of the
nonmethylated cytosine bases to uracil. This paper reports
the application of bisulfite treatment to accurately decode
the DNA sequence with known length heteroplasmic C-
tracts (nucleotide positions 16184e16193) in the hyper-
variable region I (HVI) locus by random conversion of non-
methylated cytosine to uracil.Figure 1 Sequences of (A) prebisulfite treatment and (BeD) pos
hypervariable region I (HVI) of mitochondrial DNA (mtDNA) contro
when the C-tracts are interrupted by thymine bases. Therefore, th
rogram in BeD represents the result of one independent test. S
CCCTCCCCCCCC; 1c, the sequence of TTTTTTTTCCCC; and 1d, theBuccal swabs were collected with informed consent
from volunteers after the project had been approved by the
Institutional Review Board of National Taiwan University
Hospital (Taipei, Taiwan; approval code, 201312041RINB).
DNA was extracted from the volunteers and quantified.
Prior to the bisulfite treatment, length heteroplasmy within
the HVI locus was confirmed by using the standard
sequencing method to analyze accurately the DNA
sequence from 20 unrelated individuals. These sequences
served as a comparison to the post-treated DNA sequences.
Approximately 300 ng of genomic DNA was treated with
sodium bisulfite using the MethylEasy Xceed Rapid DNA
Bisulphite Modification Kit (Human Genetic Signatures Pty
Ltd, North Ryde, NSW, Australia) in accordance with the
manufacturer’s recommendations.
Whole D-loop amplification of the prebisulfite-treated
DNA (approximately 1 ng) was performed using the primer
pair L15969 (50GGACAAATCAGAGAAAAAGTC30) and H638
(50ACCAAACCTATTTGTTTATGG3 0). Polymerase chain reac-
tion (PCR) products were sequenced using the same
sequencing primers as those used in the PCR.
To study bisulfite-treated DNA, the primer pair used to
amplify the HVI region was L16023 (50GTTYTTTYAT
GGGGAAGYAGATTTGGGT30) and H16493 (50ATACARTTCAC
TTTARCTACCC30). The amplification conditions adhered to
the manufacturer’s recommendation (PyroMark PCR kit;
QIAGEN, Turnberry Lane City, Valencia State, USA), except
the annealing temperature was modified from 56C to 50C.
The PCR products were sequenced with sequencing primerstbisulfite treatment from nucleotide positions 16159e16224 in
l region in Sample 1. Sequences typical of homoplasmy occur
e length of the C-tracts can be determined. Each electrophe-
ample 1b resulted in a sequence across the poly(C) tract of
sequence of CCCCCTCCCTC. These are tabulated in Table 1.
286 J.C.-I. Lee et al.L16031-1 (50ATGGGGAAGTAGATTTG
GGTATTAT30) for nonmethylated products and L16031-2
(50ATGGGGAAGTAGATTTGGGTACC30) for methylated prod-
ucts, by the aforementioned methods.
In our previous study, 66 of 280 samples had length
heteroplasmy within the poly(C) tract of the HVI locus.
Twenty of these samples were used in this study to inves-
tigate and determine the exact number of cytosine bases
within the poly(C) tract in HVI on either side of position
16189. The number of cytosine bases for the pretreated
samples was recorded as being counted before the adenine
immediately following the C-tract. By converting one or
more cytosine bases to uracil, an interruption in the C-tract
would be created and lead to accurate designation of the
DNA sequence and no length heteroplasmy (examples are in
Figure 1). The sequencing results of these 20 samples with
prebisulfite and postbisulfite treatment are shown in Table
1. After bisulfite treatment, variation occurs in the number
of cytosines within the C-tracts of replicates. At least two
replicates were performed on each DNA sample that had
been treated with bisulfite to determine the variation in
the number of cytosine bases within the C-tract. Only the
sequences of different C-tract lengths are shown. The
number of replicates was based on whether different
lengths of the C-tract occurred. The repeat tests for each
sample ceased only when the C-tract had different lengths;Table 1 Sequences of pre- and postbisulfite treatment of C-t
region from 20 samples.
Sample Sequences a
Pretreatment Post-treatment
1 10Cþ CCCTCCCCCCCC
TTTTTTTTCCCC
CCCCCTCCCTC
2 10Cþ CCCCCCCCCþ
CCCCCCCCCCþ
YYYYYYYYYYYþ
3 12Cþ TTYYYYTYTCYYCC
CCCCCTCCCCCCC
4 11Cþ TTTTTTTTTTTTþ
CCTTTTTTTTTTþ
CCCYCTCCCC
5 10Cþ TTTTTTTTTCCC
CCCCCCCCCþ
6 9Cþ CTTTTTTTTTT
CCCCCCCTCTCT
7 10Cþ CCCCCTCCCCCCC
CCCCCCCTCCCC
8 9Cþ CCCCCTCCCC
TTTTTTTTTTCC
9 10Cþ CCCCCCCCTCCCC
CCCCCTCCCC
10 11Cþ CCCCCTCCCC
TCCTCCCTTTTT
a The symbol “þ” represents length heteroplasmy. The cytosine nu
the adenine immediately following the C-tract. The symbol “*” repres
heteroplasmy. The lower case letter “c” indicates the mixture of de
template.12therefore the number of replicates varied for these 20
samples. There were seven samples each with three
different C-tract lengths. The other 13 samples all had two
different C-tract lengths. For these 20 samples, between
one and 12 cytosine bases were converted to uracil within
the C-tracts. Length variation among treated DNA se-
quences in each sample ranged from 1 to 4 bases. As Table 1
shows, the converted thymine bases were at random posi-
tions within the C-tract; by contrast, all or none of the
cytosine bases were converted. Of the 20 samples, only one
sample (Sample 4) exhibited all cytosine bases being con-
verted to thymine and in four samples (Samples 2, 5, 14,
and 15) no bases were converted. These samples resulted in
sequence data that could not be readily interpreted.
Length heteroplasmy occurred in long stretches of C- or T-
tracts in these samples. Partial random conversions of
cytosine bases to uracil occurred in Samples 2e4 and
Samples 12e14. These partial conversions of a base were
recorded as a “Y”, in keeping with the International Union
of Pure and Applied Chemistry (IUPAC) nomenclature sys-
tem. After the bisulfite treatment of Sample 11, there were
mixtures of deleted and nondeleted bases, which was
described in Recommendation #8 of the International So-
ciety for Forensic Genetics Commission on mitochondrial
DNA typing.12 The protocol of this technique has been
tested to confirm sequence data by different laboratories.racts in hypervariable region I of mitochondrial DNA control
Sample Sequences a
Pretreatment Post-treatment
11 10Cþ CCCCCCCc*TTC
CCCCCCCCTC
CTTTTTTTTTT
12 10Cþ CCTTTTCCCCTT
CCCYCCCYCCCY
CCCCCTCCCC
13 10Cþ CCCCCTCCCC
CCTYTTYTTYYCCC
TCCCCTTTTTTT
14 11Cþ CCCCCTCCCC
TYYTTYTTYYCþ
CCCCCCCCCCCþ
15 10Cþ CCCTTTTTTTTT
CCCCCCCCCCCþ
16 10Cþ CTTTTCCCCCC
CTTTCCCCCCCC
17 12Cþ CCCCCTCCCC
TCTTCTTCTTTC
18 11Cþ CCCCCTCCCC
TTCCTCTTTTTTTT
19 10Cþ CCCCCTCCCC
CTCCCTCCTTTT
20 12Cþ CCCCCTCCCC
TCCTCCCTTTCC
mber of sequence for prebisulfite treatment was counted before
ents indel (deleted and nondeleted, or inserted and noninserted)
leted and nondeleted (inserted and noninserted) base C of the
Length heteroplasmy test with bisulfite treatment 287Random conversions existed in both of these laboratories,
which indicate that random conversion truly occurred. The
results indicated that the method of bisulfite conversion is
a candidate method to determine the cytosine numbers in
the C-tracts for most samples. It is recommended that at
least replicate reactions covering these C-tracts are needed
to ensure that unambiguous sequences are obtained. All
observed sequence types should be reported.
Conversion of a cytosine to uracil was random and
occurred in the C-tracts and in the flanking DNA. For
example, in Figure 1 Sample a, the conversion is at nucle-
otide positions 16159, 16167, 16169, 16176, 16179, 16211,
and 16221. The bisulfite treatment also converts cytosine to
uracil in the flanking regions of the C-tracts, although the
correct sequences can be determined by sequencing the
PCR products of the pretreatment DNA.
Our previous unpublished studies using bisulfite to treat
DNA resulted in all cytosine bases being converted to uracil.
The same problem of length heteroplasmy also occurred.
The method used in this current study can randomly
convert cytosine bases in the control region into uracil
bases, which are observed as thymine after PCR and
sequencing. Uncertainty can arise if there is insufficient or
ineffective bisulfite treatment in the conversion of cytosine
bases. An uncertainty cannot be controlled or predicted;
however, accurate designation of the sequences within
different C-tract lengths occurred in this study.
In addition to providing evidence of different C-tract
lengths within one sample and its applicability to medical
and forensic mtDNA sequencing, this technique also illus-
trated the need to determine any length variation with
caution. This simple method can also be useful in the
investigation of length heteroplasmy due to 310C
transition.
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